Skip to content
Clinical Trials
About
Research
Media
Clinical Trials
About
Research
Media
Research
Publications and White Papers
A First-of-Its-Kind Drug for Concussion Protection
Astrocyte Pharmaceuticals Announces Milestones in the Fight Against Concussions: Launch of Phase 2 Clinical Trial and New $3M NIH Grant
First Human Phase 2 Trial Now Underway
Phase 2 STARFAST (Study of TBI/concussions in Australian-Rules Footballers receiving AST-004)
Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
Phase 2 Clinical Trial
Astrocyte Pharmaceuticals Inc., a clinical-stage biopharmaceutical company committed to advancing cerebroprotective therapies.
Jacquin AE, Bazarian JJ, Casa DJ, et al.
Concussion Assessment Potentially Aided by use of an Objective Multimodal Concussion Index.
J Concussion.
2021;5 1–12 http://dx.doi.org/10.1177/20597002211004333
Cathra Halabi , Lynda Norton, Kevin Norton, Wade S. Smith.
Headpulse Recovery in Recently Concussed Young Adult Athletes in Australian Football.
JAMA Network Open.
2023; 6(8):e2328633. 10.1001/jamanetworkopen.2023.28633
Bazarian J, Elbin R, Casa D, Hotz G, Neville C, Lopez R, Schnyer D, Yeargin S, Covassin T.
Validation of a Machine Learning Brain Electrical Activity-Based Index to Aid in Diagnosing Concussion Among Athletes.
JAMA Network Open.
2021;4(2) e2037349. doi:10.1001/jamanetworkopen.2020.37349
